Trigger Warning! This episode discusses topics centring around weight and weight loss, and diet culture. If you feel these topics may be triggering for you, feel free to switch to another of our episodes instead. 
In this episode, we delve into the world of diabetes treatment, exploring the benefits and side effects of Ozempic, a popular drug used to treat type 2 diabetes. We also discuss the recent shortages of Ozempic and the impact it has had on patients. We also take a closer look at alternative treatments for diabetes, specifically stem cell therapies for type 1 diabetes. We discuss the potential benefits of this cutting-edge treatment and the progress made in this field. Join us as we explore the exciting advancements in diabetes treatment and the various options available for patients.

In this episode, we discussed artificial intelligence's role in stem cell therapies by diving into the work of Cellino, a start-up biotech led by Nabiha Saklayen (co-founder) and Marina Madrid (co-founder) and Matthias Wagner. Their patented technology could hold some of the answers to how AI can help automate the stem cell manufacturing process making future treatments more affordable, scalable and standardised.
Also, stick around to the end; you might even get a cheeky book recommendation.
You can find the video we were talking about on Youtube: https://www.youtube.com/watch?v=CmnCHDoyfX

In this episode of Seriously Stem Cells, we sit down with, Thea Collier-Lawlor,  a master's student from the Stem Cells & Regenerative Therapies: From Bench to Market program at King's College London. 
Our guest shares her passion for stem cells and discusses the importance of studying this innovative field. She also sheds light on the benefits of stem cell research and provides insights into her personal experience as a stem cell researcher. 
Join us as we dive deep into the world of stem cells and explore the exciting opportunities this field has to offer.